Ignite Creation Date:
2024-05-05 @ 6:36 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00516724
Status:
COMPLETED
Last Update Posted:
2024-05-10
First Post:
2007-08-13
Brief Title:
Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Carboplatin andor Paclitaxel
Sponsor:
AstraZeneca
Organization:
AstraZeneca